These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Up-regulation of TRPM6 transcriptional activity by AP-1 in renal epithelial cells. Ikari A; Sanada A; Okude C; Sawada H; Yamazaki Y; Sugatani J; Miwa M J Cell Physiol; 2010 Mar; 222(3):481-7. PubMed ID: 19937979 [TBL] [Abstract][Full Text] [Related]
6. Reactive Oxygen Species Downregulate Transient Receptor Potential Melastatin 6 Expression Mediated by the Elevation of miR-24-3p in Renal Tubular Epithelial Cells. Hirota C; Takashina Y; Yoshino Y; Hasegawa H; Okamoto E; Matsunaga T; Ikari A Cells; 2021 Jul; 10(8):. PubMed ID: 34440664 [TBL] [Abstract][Full Text] [Related]
7. Effects of retinoids and thiazolidinediones on proliferation, insulin release, insulin mRNA, GLUT 2 transporter protein and mRNA of INS-1 cells. Blumentrath J; Neye H; Verspohl EJ Cell Biochem Funct; 2001 Sep; 19(3):159-69. PubMed ID: 11494305 [TBL] [Abstract][Full Text] [Related]
8. Rosiglitazone increases PPARgamma in renal tubular epithelial cells and protects against damage by hydrogen peroxide. Sommer M; Wolf G Am J Nephrol; 2007; 27(4):425-34. PubMed ID: 17622750 [TBL] [Abstract][Full Text] [Related]
9. RARγ-C-Fos-PPARγ2 signaling rather than ROS generation is critical for all-trans retinoic acid-inhibited adipocyte differentiation. Wang X; Yang P; Liu J; Wu H; Yu W; Zhang T; Fu H; Liu Y; Hai C Biochimie; 2014 Nov; 106():121-30. PubMed ID: 25173565 [TBL] [Abstract][Full Text] [Related]
10. TRPM6 expression and cell proliferation are up-regulated by phosphorylation of ERK1/2 in renal epithelial cells. Ikari A; Okude C; Sawada H; Yamazaki Y; Sugatani J; Miwa M Biochem Biophys Res Commun; 2008 May; 369(4):1129-33. PubMed ID: 18339311 [TBL] [Abstract][Full Text] [Related]
11. The Expression of Bone Morphogenetic Protein 2 and Matrix Metalloproteinase 2 through Retinoic Acid Receptor Beta Induced by All-Trans Retinoic Acid in Cultured ARPE-19 Cells. Gao Z; Huo L; Cui D; Yang X; Zeng J PLoS One; 2016; 11(3):e0150831. PubMed ID: 26967733 [TBL] [Abstract][Full Text] [Related]
12. Rosiglitazone inhibits insulin-like growth factor‑1-induced polycystic kidney disease cell growth and p70S6 kinase activation. Liu C; Zhang Y; Yuan L; Fu L; Mei C Mol Med Rep; 2013 Sep; 8(3):861-4. PubMed ID: 23864113 [TBL] [Abstract][Full Text] [Related]
13. Rosiglitazone induces caveolin-1 by PPARgamma-dependent and PPRE-independent mechanisms: the role of EGF receptor signaling and its effect on cancer cell drug resistance. Tencer L; Burgermeister E; Ebert MP; Liscovitch M Anticancer Res; 2008; 28(2A):895-906. PubMed ID: 18507034 [TBL] [Abstract][Full Text] [Related]
14. Rosiglitazone up-regulates glial fibrillary acidic protein via HB-EGF secreted from astrocytes and neurons through PPARγ pathway and reduces apoptosis in high-fat diet-fed mice. Kushwaha R; Mishra J; Gupta AP; Gupta K; Vishwakarma J; Chattopadhyay N; Gayen JR; Kamthan M; Bandyopadhyay S J Neurochem; 2019 Jun; 149(5):679-698. PubMed ID: 30311190 [TBL] [Abstract][Full Text] [Related]